LE CELLULISLIM
Food supplement declared in France, declaration No 2023-12-709
LE CELLULISLIM is a food supplement declared in France. Status: retrait du marché annoncé pour le 19 December 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- BIOCYTE
- Status
- Retrait du marché annoncé pour le 19 December 2027
- Form
- Gélule
- Daily dose
- 3 gélules
- Directions for use
- Prendre 3 gélules par jour avec un grand verre d’eau
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Minceur / Glycémie
Declaration 137561, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 19 December 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Taraxacum campylodes G.E.Haglund | Racine | Poudre (de plantes séchées ou broyées) | 255 mg |
| Vitis vinifera L. | Feuille | Poudre (de plantes séchées ou broyées) | 240 mg |
| Vitis vinifera L. | Pépin | Extrait sec hydroalcoolique | 180 mg |
| Vitis vinifera L. | Marc | Extrait sec aqueux | 6.06 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Caféine | not declared |
Additives
E162, E172, E508, E504, E470b
Other ingredients
maltodextrine, gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas consommer sans avis d'un professionnel de santé en cas de pathologie ou de traitement médical, en cas d'allergie à l'un des constituants (pissenlit).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Le cellulislim BIOCYTE, declared in 2024 : different composition: 4 ingredient(s) added, 6 missing